Funders › CA › Aim at Melanoma › 2022
Grants paid by Aim at Melanoma, tax year 2022
EIN 56-2427805 · Sacramento, CA · Form 990, Schedule I · NTEE G30
In tax year 2022, Aim at Melanoma (EIN 56-2427805) reported 6 grants paid totaling $496,000. Dataset version 2026.09.0, built 2026-09-03.
Every grant, 2022
| Tax year | Recipient | Match | Amount | Type | Purpose | Source filing |
|---|---|---|---|---|---|---|
| 2022 | Mtbc Melanoma Tissue Bank Consortium Sacramento, CA | A | $200,000 | paid | TISSUE BANK | 202400409349300915 |
| 2022 | Mtbc Melanoma Tissue Bank Consortium Sacramento, CA | A | $200,000 | paid | TISSUE BANK | 202301779349300420 |
| 2022 | Upmc Univ of Pittsburgh Cancer Institute Pittsburgh, PA | A | $38,000 | paid | CANCER AND MELANOMA RESEARCH | 202301779349300420 |
| 2022 | Upmc Univ of Pittsburgh Cancer Institute Pittsburgh, PA | A | $38,000 | paid | CANCER AND MELANOMA RESEARCH | 202400409349300915 |
| 2022 | Ohsu Knight Cancer Institute Portland, OR | A | $10,000 | paid | CANCER AND MELANOMA RESEARCH | 202400409349300915 |
| 2022 | Ohsu Knight Cancer Institute Portland, OR | A | $10,000 | paid | CANCER AND MELANOMA RESEARCH | 202301779349300420 |
Match tier: A Reported EIN · B Exact name and place · C Strong name match · D Probable name match · U Unresolved. Tiers C and D are inferred, not reported; see how matching works.
Recipient matching for this dataset version has not yet completed its independent precision check. Tier A rows carry the EIN the filer reported; tiers B–D are the matcher's inference and should be read as leads until the check is published on the methodology page.
Derived from IRS Form 990 e-file XML. Dataset version 2026.09.0, built 2026-09-03. All years for this funder.
The same organization elsewhere in the program: exempt status and filing health · federal awards · grant guidance · open opportunities.
This is informational only, derived from public data on the dates shown. It is not an eligibility determination, and not legal, tax, or accounting advice. Verify against the official source before relying on it.